Cargando…
Inhibiting ALK-TOPK signaling pathway promotes cell apoptosis of ALK-positive NSCLC
T-LAK cell-oriented protein kinase (TOPK) is a potential therapeutic target in tumors. However, its role in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) has not been reported. Here, we found that TOPK was highly expressed in ALK-positive NSCLC. Additionally, ALK was i...
Autores principales: | Xiao, Juanjuan, Zhang, Lu, Yi, Huijun, Zou, Ling, Mo, Jianmei, Xue, Feng, Zheng, Jinhua, Huang, Yingze, Lu, Hui, Wu, Hansheng, Xue, Peipei, Zhang, Xin, He, Lifei, Li, Zhaoxin, Pang, Shigui, Qiao, Guibin, Duan, Qiuhong, Zhu, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515217/ https://www.ncbi.nlm.nih.gov/pubmed/36167821 http://dx.doi.org/10.1038/s41419-022-05260-3 |
Ejemplares similares
-
Phosphorylation of TOPK at Y74, Y272 by Src increases the stability of TOPK and promotes tumorigenesis of colon
por: Xiao, Juanjuan, et al.
Publicado: (2016) -
ALK and NSCLC: Targeted therapy with ALK inhibitors
por: Hallberg, Bengt, et al.
Publicado: (2011) -
ALK Inhibitors in the Treatment of ALK Positive NSCLC
por: Khan, Muhammad, et al.
Publicado: (2019) -
Targeting the COX2/MET/TOPK signaling axis induces apoptosis in gefitinib-resistant NSCLC cells
por: Xiao, Juanjuan, et al.
Publicado: (2019) -
Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC
por: Zhu, Qian, et al.
Publicado: (2017)